{"id":"https://openalex.org/W4281652553","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.10043","title":"Patterns of relapse after immunotherapy in patients with high-risk neuroblastoma.","display_name":"Patterns of relapse after immunotherapy in patients with high-risk neuroblastoma.","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4281652553","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.10043"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2022.40.16_suppl.10043","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.10043","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.10043","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069514689","display_name":"Scott Moerdler","orcid":"https://orcid.org/0000-0002-2067-4817","observed_orcids":["https://orcid.org/0000-0002-2067-4817"]},"institutions":[{"id":"https://openalex.org/I4390039325","display_name":"Rutgers Cancer Institute","ror":"https://ror.org/0060x3y55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I102322142","https://openalex.org/I4390039302","https://openalex.org/I4390039325"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Moerdler","raw_affiliation_strings":["Department of Pediatrics, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ;","institution_ids":["https://openalex.org/I4390039325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000459362","display_name":"Arlene H. Naranjo","orcid":"https://orcid.org/0000-0001-7737-4324","observed_orcids":["https://orcid.org/0000-0001-7737-4324"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arlene Naranjo","raw_affiliation_strings":["Children's Oncology Group Statistics and Data Center, University of Florida, Gainesville, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Oncology Group Statistics and Data Center, University of Florida, Gainesville, FL;","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077521470","display_name":"Sheena Cretella Tenney","orcid":"https://orcid.org/0000-0002-3255-8450","observed_orcids":["https://orcid.org/0000-0002-3255-8450"]},"institutions":[{"id":"https://openalex.org/I4210134079","display_name":"Children's Oncology Group","ror":"https://ror.org/03yyg2352","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210134079"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sheena Tenney","raw_affiliation_strings":["Children's Oncology Group, Gainesville, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Oncology Group, Gainesville, FL;","institution_ids":["https://openalex.org/I4210134079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036062620","display_name":"Rochelle Bagatell","orcid":"https://orcid.org/0000-0002-5729-8819","observed_orcids":["https://orcid.org/0000-0002-5729-8819"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rochelle Bagatell","raw_affiliation_strings":["Children's Hospital of Philadelphia, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Hospital of Philadelphia, Philadelphia, PA;","institution_ids":["https://openalex.org/I1335321130"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055148154","display_name":"Alice Lin-Tsing Yu","orcid":"https://orcid.org/0000-0003-2444-0505","observed_orcids":["https://orcid.org/0000-0003-2444-0505"]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alice L. Yu","raw_affiliation_strings":["University of California, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Diego, CA;","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003639088","display_name":"Wendy B. London","orcid":"https://orcid.org/0000-0003-3571-6538","observed_orcids":["https://orcid.org/0000-0003-3571-6538"]},"institutions":[{"id":"https://openalex.org/I4210166317","display_name":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center","ror":"https://ror.org/05k11pb55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113","https://openalex.org/I4210117453","https://openalex.org/I4210166317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy B. London","raw_affiliation_strings":["Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA;","institution_ids":["https://openalex.org/I4210166317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"40","issue":"16_suppl","first_page":"10043","last_page":"10043"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11173","display_name":"Neurofibromatosis and Schwannoma Cases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.9490000009536743},{"id":"https://openalex.org/keywords/high-risk-neuroblastoma","display_name":"high-risk neuroblastoma","score":0.8619999885559082},{"id":"https://openalex.org/keywords/anti-gd2-immunotherapy","display_name":"anti-GD2 immunotherapy","score":0.9049999713897705},{"id":"https://openalex.org/keywords/dinutuximab","display_name":"dinutuximab","score":0.9800000190734863},{"id":"https://openalex.org/keywords/isotretinoin","display_name":"isotretinoin","score":0.9890000224113464},{"id":"https://openalex.org/keywords/recurrence-patterns","display_name":"recurrence patterns","score":0.7139999866485596},{"id":"https://openalex.org/keywords/bone-marrow-relapse","display_name":"bone marrow relapse","score":0.9350000023841858},{"id":"https://openalex.org/keywords/mycn-amplification","display_name":"MYCN amplification","score":0.7879999876022339},{"id":"https://openalex.org/keywords/ploidy","display_name":"ploidy","score":0.6159999966621399},{"id":"https://openalex.org/keywords/mitosis-karyorrhexis-index","display_name":"mitosis-karyorrhexis index","score":0.8240000009536743}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9300562143325806},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.686757504940033},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6488603949546814},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.515673041343689},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4665659964084625},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4597077965736389},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2756275534629822}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2022.40.16_suppl.10043","doi":"https://doi.org/10.1200/jco.2022.40.16_suppl.10043","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2022.40.16_suppl.10043","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281779393","https://openalex.org/W3113349188","https://openalex.org/W3004101682","https://openalex.org/W4399281530","https://openalex.org/W4312174151","https://openalex.org/W4283460025","https://openalex.org/W4285491244","https://openalex.org/W3213774448","https://openalex.org/W4303457093","https://openalex.org/W4410898682"],"abstract_inverted_index":{"10043":[0],"Background:":[1],"While":[2,387],"the":[3,16,30,39,66,166,211,234,276,293,316,342,350,356,371,390,397,409],"addition":[4],"of":[5,33,41,47,59,68,72,83,85,107,168,185,231,265,278,307,366,375,392],"anti-GD2":[6],"immunotherapy":[7,42,69,388],"led":[8],"to":[9,35,54,64,116,124,301,324,378,407],"improvement":[10],"in":[11,13,49,74,206,233,349,394],"outcomes":[12],"patients":[14,75,108,114,155,267,280,311,337,367,381],"on":[15,43,70,88,109,173,183,327,368],"Children\u2019s":[17],"Oncology":[18],"Group":[19],"(COG)":[20],"ANBL0032":[21,110,174],"study,":[22],"relapse":[23,48,73,86,149,170,232,270,297,320,346,376],"remains":[24,389],"a":[25,80],"concern.":[26],"Prior":[27],"studies":[28],"demonstrated":[29],"prognostic":[31],"importance":[32],"time":[34,167],"first":[36,169],"relapse,":[37],"however,":[38,275,335],"effect":[40],"timing":[44],"and":[45,95,120,143,148],"patterns":[46,71],"neuroblastoma":[50],"(NBL)":[51],"have":[52],"yet":[53],"be":[55],"evaluated.":[56],"The":[57,188,225],"purpose":[58],"this":[60,363,395,400],"exploratory":[61,364,402],"analysis":[62,106,365,403],"was":[63,111,162],"describe":[65],"impact":[67],"with":[76,93,281,295,312,318,338,344,383],"high-risk":[77],"NBL,":[78],"including":[79,113,132],"descriptive":[81,105],"comparison":[82],"sites":[84,150],"based":[87,182,326],"post-consolidation":[89],"treatment":[90,304,328,391],"received":[91],"[dinutuximab":[92],"cytokines":[94],"isotretinoin":[96,99],"(DIN)":[97],"vs":[98,287,355,385],"alone":[100],"(ISO)].":[101],"Methods:":[102],"A":[103,262],"retrospective,":[104],"performed,":[112],"randomized":[115,212,235],"DIN":[117,125,154,201,279,357,384],"or":[118],"ISO":[119,127,196,222,266,351],"those":[121],"non-randomly":[122],"assigned":[123],"after":[126,171],"arm":[128],"closure.":[129],"Pt":[130],"characteristics":[131],"age,":[133],"stage,":[134],"MYCN":[135,308,313,339],"amplification":[136],"status,":[137],"tumor":[138],"grade,":[139],"mitosis-karyorrhexis":[140],"index":[141],"(MKI)":[142],"ploidy":[144],"were":[145,151,180],"summarized":[146],"descriptively":[147],"tabulated.":[152],"For":[153],"who":[156],"subsequently":[157],"relapsed,":[158,204],"overall":[159],"survival":[160],"(OS)":[161],"calculated":[163],"starting":[164],"from":[165,399],"enrollment":[172],"(\u201cpost-relapse":[175],"OS\u201d).":[176],"Kaplan-Meier":[177],"OS":[178],"curves":[179],"generated":[181],"site":[184,230,374],"relapse.":[186,413],"Results:":[187],"analytic":[189],"cohort":[190,213,236],"included":[191],"1,431":[192],"(DIN":[193,219],"=":[194,197,215,220,223],"1,327;":[195],"104)":[198],"patients.":[199],"Among":[200,289,310],"patients,":[202,292],"492":[203],"many":[205],">":[207],"1":[208],"site.":[209],"In":[210,362],"(n":[214],"248),":[216],"122":[217],"relapsed":[218,291],"68/144;":[221],"54/104).":[224],"frequencies":[226],"(DIN;":[227],"ISO)":[228],"by":[229],"were:":[237],"bone":[238,296],"(53%;":[239],"54%),":[240],"CNS":[241],"(16%;":[242],"11%),":[243],"lymph":[244],"node":[245],"(13%;":[246],"17%),":[247,250],"abdominal":[248],"(10%;":[249],"paraspinal":[251],"(6%;":[252],"2%),":[253],"liver":[254],"(3%;":[255],"4%),":[256],"other":[257],"soft":[258],"tissue":[259],"(22%;":[260],"7%).":[261],"higher":[263,285,348],"proportion":[264,277,294,317,343],"had":[268],"marrow":[269,319,345],"(29.4%":[271],"DIN;":[272,331],"48.2%":[273],"ISO);":[274],"lung":[282],"relapses":[283],"appeared":[284,347],"(9%":[286],"2%).":[288],"all":[290],"did":[298,321],"not":[299,322],"appear":[300,323],"differ":[302,325,379],"between":[303,380],"groups,":[305],"regardless":[306],"status.":[309],"amplified":[314],"disease,":[315,341],"[21/149":[329],"(14.1%)":[330],"3/20":[332],"(15.0%)":[333],"ISO];":[334],"among":[336],"non-amplified":[340],"group":[352,358],"[16/23;":[353],"69.6%]":[354],"[52/193":[359],"(26.9%)].":[360],"Conclusions:":[361],"COG":[369],"ANBL0032,":[370],"pattern":[372],"for":[373,411],"appears":[377],"treated":[382],"ISO.":[386],"choice":[393],"population,":[396],"findings":[398],"retrospective":[401],"warrant":[404],"further":[405],"investigation":[406],"decrease":[408],"risk":[410],"post-immunotherapy":[412],"Clinical":[414],"trial":[415],"information:":[416],"NCT00026312.":[417]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2022-06-13T00:00:00"}